First Response Group has been at the heart of the nation’s fight against the Coronavirus having been brought in by the University of Oxford to bolster security at the latter’s COVID-19 research facility.
The company was recommended for the highly important security detail after successfully demonstrating its expertise and reliability to the University of Oxford during the first national lockdown.
Founded in 2007 by directors Jamal Tahlil and Edgar Chibaka, First Response Group provides security, fire and facilities management services to a wide range of clients in the public and private sectors.
The COVID-19 Oxford Vaccine Trial has been run by the University of Oxford’s Jenner Institute and the Oxford Vaccine Group clinical teams. It has been conducted in collaboration with multiple study sites across the UK and internationally, including a temporary research installation on the University of Oxford’s grounds.
After a full site risk assessment, First Response Group recommended a 24/7 security guarding detail consisting of three security officers on the premises during the day and two at night to ensure robust protection for the trial patients, research staff and the sensitive clinical data.
First Response Group’s Security Industry Authority-licensed security officers control all entrances and exits through the facility day and night. While safeguarding the safety and integrity of the project, the officers also ensure that distancing measures are followed, challenge anti-social behaviour and monitoring the area for suspicious activity.
Dedicated site supervisor
To ensure fast and consistent communication with the University of Oxford’s management, First Response Group allocated a dedicated site supervisor to provide a senior level presence at the site from Monday to Friday. The site supervisor acts as the main point of contact for the University of Oxford’s management, dealing with any issues as and when they arise in real-time.
Oto Velička, senior buildings and facilities manager at the University of Oxford, informed Security Matters: “I would like to thank the First Response Group for the outstanding quality of service the company provides for our COVID-19 Oxford Vaccine Trial at the University of Oxford. When we approached the company asking for support, the management team immediately engaged with us on a highly professional level and was able to scope, suggest and implement a made-to-measure solution perfectly suiting our needs.”
Velička continued: “The on-site team members are highly competent, professional, co-operative and have a comprehensive understanding of our business needs and the sensitivity of our activity. They’ve proven over and over that we can rely on them for all of our security needs, bringing complete peace of mind to our operation 24 hours per day, seven days a week.”
Simon Alderson, CEO at the First Response Group, added: “Without question, this has to be one of the most high-profile security operations with which we’ve been involved in. Indeed, it’s one of worldwide importance. Being chosen to support the University of Oxford in this clinical trial is a ringing endorsement of the First Response Group. It’s an honour to have played a part in ensuring the security of the vaccine, staff and trial patients in the lead-up to its national roll-out.”